Sly Syndrome Completed Phase 2 Trials for Cyclosporine (DB00091)

IndicationStatusPhase
DBCOND0040268 (Sly Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01043640Allogeneic Bone Marrow Transplant for Inherited Metabolic DisordersTreatment